Thomas W Hawkeswood is Pres. Pharma Prod Delivery Div of Catalent, Inc.. Currently has a direct ownership of 7,533 shares of CTLT, which is worth approximately $457,629. The most recent transaction as insider was on Aug 24, 2023, when has been sold 147 shares (Common Stock) at a price of $44.72 per share, resulting in proceeds of $6,573. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.53K
0% 3M change
0% 12M change
Total Value Held $457,629

Thomas W Hawkeswood Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 24 2023
SELL
Open market or private sale
$6,573 $44.72 p/Share
147 Reduced 1.91%
7,533 Common Stock
Aug 23 2023
BUY
Grant, award, or other acquisition
-
268 Added 3.37%
7,680 Common Stock
Aug 01 2023
SELL
Open market or private sale
$12,376 $47.97 p/Share
258 Reduced 4.81%
5,106 Common Stock
Aug 01 2023
BUY
Grant, award, or other acquisition
-
2,306 Added 23.73%
7,412 Common Stock
Oct 10 2022
SELL
Open market or private sale
$72,038 $77.46 p/Share
930 Reduced 14.78%
5,364 Common Stock
Aug 25 2022
SELL
Open market or private sale
$69,140 $103.04 p/Share
671 Reduced 9.63%
6,294 Common Stock
Aug 24 2022
BUY
Grant, award, or other acquisition
-
1,253 Added 15.25%
6,965 Common Stock
TWH

Thomas W Hawkeswood

Pres. Pharma Prod Delivery Div
Somerset, NJ

Track Institutional and Insider Activities on CTLT

Follow Catalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTLT shares.

Notify only if

Insider Trading

Get notified when an Catalent, Inc. insider buys or sells CTLT shares.

Notify only if

News

Receive news related to Catalent, Inc.

Track Activities on CTLT